RxDoctor Payments Data

Zhiyong Ren, PhD

Anatomic Pathology & Clinical Pathology · Atlantic City, NJNPI 1275767097

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Medtronic at 25.4% of the total. 2025 is the largest year on record at $269, 9.7 times the $28 reported in 2019. Among anatomic pathology & clinical pathology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$569in general payments, 2019–2025

Across 6 payments — averaging $94.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$144
  • Abbott$141
  • AstraZeneca$125
  • Johnson & Johnson$111
  • Roche Diagnostics Corporation$28
  • Lilly USA, LLC$19

What the payments were for

  • Food & beverage$569100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$569 in reported general payments places this provider in the 90th percentile of 218 anatomic pathology & clinical pathology providers in New Jersey.

See all anatomic pathology & clinical pathology providers in New Jersey

Medicare billing

Part B allowed, 2024
$162,720
Medicare patients
1,118
Services billed
4,659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Atlantic City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →